F. Mingozzi
Genetics · 2006–2017
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 55 citations into it; #3,737 of 6,854 by trust here, #879 by citations
- Molecular Biology — 53 citations into it; #10,829 of 17,773 by trust here, #3,803 by citations
- Infectious Diseases — 7 citations into it
- Immunology — 5 citations into it
Whom F. Mingozzi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts F. Mingozzi overall
Papers from F. Mingozzi's perspective
Ordered by how strongly the researchers F. Mingozzi trusts endorse each paper. Same corpus, a different order for every researcher.
- In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses (Journal of Virology)
- AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma (Science)
- Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. (New England Journal of Medicine)
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (Journal of the American Medical Association (JAMA))
- Engineering adeno-associated viruses for clinical gene therapy (Nature reviews genetics)
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors (Human Gene Therapy)
- In vivo genome editing using Staphylococcus aureus Cas9
- Single‐Dose Gene‐Replacement Therapy for Spinal Muscular Atrophy (New England Journal of Medicine)
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain (Nature Biotechnology)
- Antigen-presenting cell function in the tolerogenic liver environment (Nature reviews. Immunology)
Their papers
- Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges (2011) — 832 citations
- Safety and efficacy of gene transfer for Leber's congenital amaurosis. (2008) — 2,123 citations
- Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response (2006) — 2,132 citations
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy. (2013) — 901 citations
- Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. (2009) — 816 citations
- Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B (2011) — 1,797 citations
- Emerging Issues in AAV-Mediated In Vivo Gene Therapy (2017) — 745 citations
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B (2014) — 1,138 citations
- CD8+ T-cell responses to adeno-associated virus capsid in humans (2007) — 736 citations